Moderna reported clinical data on its COVID-19 vaccine
On Sept. 15, 2021, Moderna announced new analysis suggesting that the COVID-19 vaccine was highly effective against circulating…
InBios received FDA EUA for COVID-19 IgG antibody rapid test
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
Regeneron announced U.S. Government agreement to purchase additional REGEN-COV antibody cocktail
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
City of Hope trial was first to test an investigational COVID-19 vaccine in immunocompromised bone marrow transplant
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
NIH provided $185 million for research to advance understanding of how human genome functions
On Sept. 9, 2021, the National Institutes of Health (NIH) announced that it was providing approximately $185 million…
T2 Biosystems T2SARS-CoV-2 panel proved capable of detecting Mu B.1.621 and Iota B.1.526 variants of SARS-CoV-2 virus
On Sept. 9, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detected…
Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenza
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
Resilience to manufacture mRNA for Moderna’s COVID-19 vaccine
On Sept. 8, 2021, National Resilience announced an agreement to manufacture mRNA for the Moderna COVID-19 vaccine. Under…
Takeda announced manufacture and provision of 150 million doses of Novavax COVID-19 vaccine candidate to the government of Japan
On Sept. 7, 2021, Takeda Pharmaceutical announced the Government of Japan’s Ministry of Health, Labour and Welfare purchase…
Biotechnology | Diagnostics | Disease | Environmental | Genomics | Life Science News | NIH | Oncology
NIH study illuminated origins of lung cancer in never smokers
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
Pfizer and BioNTech submitted a variation to EMA with data in support of a booster dose of COMIRNATY
On Sept. 6, 2021, Pfizer and BioNTech announced that they had submitted a variation to the European Medicines…
Moderna announced submission of data to EMA for its COVID-19 vaccine booster
On Sept. 3, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) with the…
Moderna announced submission of initial data to U.S. FDA for Its COVID-19 vaccine booster
On Sept. 1, 2021, Moderna announced it had initiated its submission to the U.S. Food and Drug Administration…
The United Nations announced the end of leaded gasoline use in vehicles worldwide
On Aug. 30, 2021, the United Nations announced the global phase-out of leaded fuel, a milestone for multilateralism,…
Biotechnology | COVID-19 | Life Science News | NIH | Therapeutics | Vaccine
Oragenics SARS-CoV-2 spike protein produced neutralizing antibodies with Intramuscular and intranasal adjuvants
On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Monoclonal antibody treatment combo reduced hospitalization among high-risk patients with COVID-19
On Aug. 30, 2021, the Mayo Clinic reported that in an observational study the combination of casirivimab and…
Spacestation astronauts successfully demonstrated DNA repair in space using CRISPR technology
On Aug. 27, 2021, National Aeronautics and Space Administration (NASA) Space station astronauts successfully demonstrated DNA repair in…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
Study confirmed virus variants reduce protection against COVID-19
On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study from found that blood…
Pfizer and BioNTech announced collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses
On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…
INOVIO received authorization to conduct phase 3 efficacy trial of COVID-19 DNA vaccine candidate, INO-4800 in Brazil
On Aug. 26, 2021, Inovio Pharma announced that it had received regulatory authorization from Brazil’s ANVISA (Agencia Nacional…
Anixa Biosciences’ Covid-19 compounds expected to be effective against the Delta variant
On Aug. 25, 2021, Anixa Biosciences announced that a genomic variant analysis indicateed that its potential compounds may…
Moderna completed submission of BLA to the Food and Drug Administration for its COVID-19 vaccine
On Aug. 25, 2021, Moderna announced it had completed the rolling submission process for its Biologics License Application…
Pfizer and BioNTech initiated rolling submission of SBLA to U.S. FDA for booster dose of COMIRNATY in individuals 16 and Older
On Aug. 25, 2021, Pfizer and BioNTech announced the initiation of a supplemental Biologics License Application (sBLA) to…
Pfizer-BioNTech COVID-19 vaccine COMIRNATY received full U.S. FDA approval for individuals 16 years and older
On Aug. 23, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
Amyris achieved promising in-vivo results for intranasal delivery of RNA/NLC vaccine
On Aug. 20, 2021, Amyris announced promising in-vivo results in a study of its licensed RNA vaccine through…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
Vaccines still effective against Delta variant of concern, says Oxford-led study of the COVID-19 Infections Survey
On Aug. 19, 2021, the University of Oxford reported that obtaining two vaccine doses remained the most effective…
Moderna announced supply agreement with Canada for expanded supply of COVID-19 Vaccine from 2022 – 2024
On Aug. 16, 2021, Moderna announced a revised supply agreement with the Government of Canada for up to…
FDA approved Merck’s hypoxia-inducible factor-2 alpha inhibitor WELIREG (belzutifan)
On Aug. 13, 2021, Merck announced that the U.S. Food and Drug Administration (FDA) had approved WELIREG, an…
Moderna announced FDA authorization of third dose of COVID-19 vaccine for immunocompromised individuals
On Aug. 13, 2021, Moderna announced that the Food and Drug Administration (FDA) had approved an update to…
The Department of Veterans Affairs expanded mandate for COVID-19 vaccines among VHA employees
On Aug. 12, 2021, the U.S. Department of Veterans Affairs (VA) announced that it expanded his previous COVID-19…